【obagi c clarifying serum rx】Idexx: 4Q Earnings Snapshot

WESTBROOK,obagi c clarifying serum rx Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported fourth-quarter earnings of $85.6 million.

The Westbrook, Maine-based company said it had net income of 98 cents per share.

【obagi c clarifying serum rx】Idexx: 4Q Earnings Snapshot


The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 90 cents per share.

【obagi c clarifying serum rx】Idexx: 4Q Earnings Snapshot


The Animal diagnostic and health care company posted revenue of $549.4 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $545.6 million.

【obagi c clarifying serum rx】Idexx: 4Q Earnings Snapshot


For the year, the company reported profit of $377 million, or $4.26 per share. Revenue was reported as $2.21 billion.


Idexx expects full-year earnings to be $4.66 to $4.78 per share, with revenue in the range of $2.38 billion to $2.42 billion.


Idexx shares have risen 14 percent since the beginning of the year. The stock has increased 14 percent in the last 12 months.


_____


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDXX at https://www.zacks.com/ap/IDXX


View comments


推荐内容